Association Between Adherence to Diuretic Therapy and Health Care Utilization in Patients with Heart Failure
Overview
Authors
Affiliations
Study Objective: To determine the relationship between adherence to diuretic therapy and health care utilization.
Design: Prospective, observational study.
Setting: University-affiliated medical center.
Patients: Forty-two patients with heart failure.
Intervention: Electronic monitoring of adherence to diuretic therapy (percentage of diuretic prescription container openings) and to scheduling (percentage of container openings within a specific time).
Measurements And Main Results: All patients were prescribed a diuretic, most commonly furosemide (88%). Patients varied widely in adherence to therapy (mu = 72% +/- 30%) and to scheduling (mu = 43% +/- 30%). Education was a predictor of drug-taking adherence (p=0.0062) but not of scheduling adherence. Log-linear models revealed that poor scheduling adherence was associated with increased cardiovascular-related hospitalizations (chi2 11.63, p=0.0006) and predicted more heart failure-related hospitalizations (chi2 4.04, p=0.0444). In contrast, neither measure was significantly associated with cardiovascular- or heart failure-related emergency department visits. We found a moderate correlation between scheduling adherence and taking adherence (r = 0.6513).
Conclusion: Patients taking a greater proportion of diuretic agents on schedule may decrease the risk of cardiovascular- and heart failure-related hospitalizations. If these findings are confirmed by a larger study, interventions to improve adherence and patient health outcomes should consider the timing of doses as well as the number of daily doses of a diuretic.
Tang Y, Yan J, Tang L, Liu X Int J Cardiol Cardiovasc Risk Prev. 2022; 13:200128.
PMID: 35308899 PMC: 8924309. DOI: 10.1016/j.ijcrp.2022.200128.
Wu J, Moser D J Card Fail. 2021; 27(8):848-856.
PMID: 34364662 PMC: 9000523. DOI: 10.1016/j.cardfail.2021.03.004.
Simpson J, Jackson C, Haig C, Jhund P, Tomaszewski M, Gardner R Eur Heart J Cardiovasc Pharmacother. 2020; 7(4):296-301.
PMID: 32597982 PMC: 8302254. DOI: 10.1093/ehjcvp/pvaa071.
Riegel B, Lee S, Hill J, Daus M, Osei Baah F, Wald J Heart Lung. 2019; 48(3):179-185.
PMID: 30638609 PMC: 6486853. DOI: 10.1016/j.hrtlng.2018.12.008.
Wu J, Song E, Moser D Heart Lung. 2015; 44(4):276-81.
PMID: 25979573 PMC: 4470745. DOI: 10.1016/j.hrtlng.2015.03.006.